{"DataElement":{"publicId":"2766425","version":"1","preferredName":"Renal Cell Carcinoma Eastern Cooperative Oncology Group Risk Factor Stage Grouping Type","preferredDefinition":"the stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, category defined by the Eastern Cooperative Oncology Group, a cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs, for renal cell carcinoma, cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"RCC_RF_STGGRP_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2766423","version":"1","preferredName":"Renal Cell Carcinoma Eastern Cooperative Oncology Group Risk Factor Stage Grouping","preferredDefinition":"information related to the Eastern Cooperative Oncology Group, a cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs, stage grouping, an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, for renal cell carcinoma, cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"RCC_ECOG_RF_STGGRP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2428360","version":"1","preferredName":"Renal Cell Carcinoma","preferredDefinition":"Cancer that develops in the lining of the renal tubules, which filter the blood and produce urine.","longName":"C9385","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Cell Carcinoma","conceptCode":"C9385","definition":"A carcinoma arising from the renal parenchyma.  There is a strong correlation between cigarette smoking and the development of renal cell carcinoma.  The clinical presentation includes : hematuria, flank pain and a palpable lumbar mass.  A high percentage of renal cell carcinomas are diagnosed when an ultrasound is performed for other purposes.  Radical nephrectomy is the standard intervention procedure.  Renal cell carcinoma is generally considered to be resistant to radiation treatment and chemotherapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0826-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2766421","version":"1","preferredName":"Eastern Cooperative Oncology Group Risk Factor Stage Grouping","preferredDefinition":"The Eastern Cooperative Oncology Group (ECOG) was established in 1955. This is a cooperative group (Philadelphia, PA) funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.:Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25491:C17103:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Eastern Cooperative Oncology Group","conceptCode":"C25491","definition":"A cooperative group funded primarily by the NCI, one of the largest clinical cancer research organizations in the US, incorporating universities, medical centers, Community Clinical Oncology Programs, and Cooperative Group Outreach Programs with almost 6000 physicians, nurses, pharmacists, statisticians, and clinical research associates from the US, Canada, and South Africa. ECOG has more than 90 active clinical trials in all types of adult malignancies. Annual accrual is 6,000 patients, with more than 20,000 patients in follow-up.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51FF4890-E654-169F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"ONEDATA","dateModified":"2008-07-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51FF4890-E665-169F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2766424","version":"1","preferredName":"Renal Cell Carcinoma Risk Factor Stage Grouping Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"RCC_RF_STGGRP_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intermediate high risk group","valueDescription":"Intermediate high risk group","ValueMeaning":{"publicId":"2766426","version":"1","preferredName":"Intermediate high risk group","longName":"2766426","preferredDefinition":"pT1b G 3-4 N0 (or pNX where clinically N0) M0\r\npT2b G 1-2 N0 (or pNX where clinically N0) M0\r\npT2 G 3-4 N0 (or pNX where clinically N0) M0\r\npT3a G 1-2 (as long as pT3a is not due to adrenal involvement) N0 (or pNX where clinically N0) M0\r\nPatients with microvascular invasion of the renal vein of pT1a-pT3a (as long as pT3a is not due to adrenal involvement) N0 (or pNX where clinically N0) M0","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51FF73E7-F6EF-202E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"51FE8298-F1C7-1D8D-E044-0003BA3F9857","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"ONEDATA","dateModified":"2008-07-14","deletedIndicator":"No"},{"value":"Very high risk group","valueDescription":"Very high risk group","ValueMeaning":{"publicId":"2766427","version":"1","preferredName":"Very high risk group","longName":"2766427","preferredDefinition":"pT3a G 3-4 (as long as pT3a is not due to adrenal involvement) N0 (or pNX where clinically N0) M0\r\npT3b-c G any N0 (or pNX where clinically N0) M0\r\npT4 G N0 (or pNX where clinically N0) M0\r\npT any G any N+  Patients with microvascular invasion of the renal vein with above other characteristics","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51FE81B5-9AD5-228A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"51FE8298-F1D9-1D8D-E044-0003BA3F9857","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"ONEDATA","dateModified":"2008-07-14","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6332FCA8-8AB0-1FC8-E040-BB89AD432A49","beginDate":"2009-02-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-02-18","modifiedBy":"ONEDATA","dateModified":"2009-02-18","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559653","version":"1","preferredName":"Other","longName":"2559653","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B612-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2023-12-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887210B1-450C-13BD-E040-BB89AD436340","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"},{"value":"Any T, Any N, M1","valueDescription":"Any T, Any N, M1","ValueMeaning":{"publicId":"2576688","version":"1","preferredName":"Any T, Any N, M1","longName":"2576688","preferredDefinition":"Any T, Any N, M1","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F89D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-24","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-24","modifiedBy":"CAMPBELB","dateModified":"2005-10-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"887210B1-4520-13BD-E040-BB89AD436340","beginDate":"2010-06-07","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-06-07","modifiedBy":"ONEDATA","dateModified":"2010-06-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"51FF4890-E677-169F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"SHIDED","dateModified":"2010-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811954","version":"1","longName":"Eligibility Criteria","context":"CTEP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Pathologic stage","type":"Preferred Question Text","description":"Pathologic stage","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Disease Stage","url":null,"context":"CTEP"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"51FF5A2D-E708-1B23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-07-14","modifiedBy":"SHIDED","dateModified":"2010-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}